Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors
Completed · Phase 1
Conditions studied: Advanced Cancer
In brief
This study evaluated the safety, tolerability, pharmacokinetic profile and treatment effect of a new drug known as BGB-A317 in participants with advanced tumors.
Key facts
- Study ID
- NCT02407990
- Run by
- BeiGene
- People needed
- 451
- Starts
- 2015-06-02
- Expected to finish
- 2020-08-12
- Last updated by the study team
- 2021-11-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Oncology Consultants, P.A. — Houston, Texas, United States
- Chris O'Brien Lifehouse — Camperdown, New South Wales, Australia
- Prince of Wales Hospital — Sydney, New South Wales, Australia
- Tasman Oncology Research Ltd — Southport, Queensland, Australia
- Princess Alexandra Hospital — Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital — Adelaide, South Australia, Australia
- The Queen Elizabeth Hospital — Woodville South, South Australia, Australia
- Monash Health — Clayton, Victoria, Australia
- Peter MacCallum Cancer Centre — East Melbourne, Victoria, Australia
- Austin Health Hospital — Heidelberg, Victoria, Australia
- Cabrini Hospital — Malvern, Victoria, Australia
- Nucleus Network — Melbourne, Victoria, Australia
- Royal Melbourne Hospital — Melbourne, Victoria, Australia
- Linear Clinical Research/Sir Charles Gairdner Hospital — Nedlands, Western Australia, Australia
- Auckland City Hospital — Grafton, New Zealand
- Waikato — Hamilton, New Zealand
- Wellington Hospital — Wellington, New Zealand
- Seoul National University Bundang Hospital — Seongnam, Kyeonggi-do, South Korea
- Seoul National University Hospital — Seoul, South Korea
- Asan Medical Center — Seoul, South Korea
- Kaohsiung Chang Gung Memorial Hospital — Kaohsiung City, Taiwan
- National Cheng Kung University Hospital — Tainan, Taiwan
- Taipei Veterans General Hospital — Taipei, Taiwan
- National Taiwan University Hospital — Taipei, Taiwan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.